Answers are grounded in this paper and cite their sources.
Antrodia cinnamomea is a Taiwan-endemic medicinal fungus with reported anti-inflammatory and anticancer activities. Circulating tumor cells (CTCs) contribute to metastasis and therapy resistance in non-small cell lung cancer (NSCLC). This study investigated whether stress-adaptive programs supporting CTC survival can be pharmacologically disrupted by GKB202, a purified derivative of A. cinnamomea . Patient-derived NSCLC CTCs were isolated and treated with GKB202 followed by RNA sequencing. Differential expression, pathway enrichment, and rank-rank hypergeometric overlap (RRHO) analyses were performed using a public NSCLC bone metastasis dataset (GSE175601). Functional assays in A549 cells assessed proliferation, migration, and invasion. MT1E protein expression was examined by Western blotting, and metabolomic profiling was conducted using UPLC-QTOF/MS. Untreated CTCs showed enrichment of migration- and lipid metabolism-related programs, whereas GKB202 treatment was associated with enrichment of stress-adaptive and detoxification pathways. Metallothionein-1E (MT1E) expression increased following GKB202 treatment. GKB202 reduced CTC viability and its combination with cisplatin produced a greater reduction in viability than either treatment alone in patient-derived CTC cultures. In A549 cells, GKB202 reduced proliferation and migration, accompanied with time-dependent changes in MT1E protein expression. Exploratory metabolomic profiling showed alterations in lipid-associated metabolic pathways consistent with stress-responsive regulation. These findings suggest that GKB202 is associated with changes in stress-adaptive molecular and metabolic programs in NSCLC models, together with reductions in selected malignant phenotypes and modulation of MT1E-associated responses. By potentially modulating compensatory stress responses in CTCs, GKB202 may increase their vulnerability to therapeutic stress, a possibility that warrants further investigation in the context of CTC-associated metastatic progression in NSCLC.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: